BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 14707131)

  • 1. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
    Ashikari-Hada S; Habuchi H; Kariya Y; Itoh N; Reddi AH; Kimata K
    J Biol Chem; 2004 Mar; 279(13):12346-54. PubMed ID: 14707131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
    Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M
    J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture.
    Sugaya N; Habuchi H; Nagai N; Ashikari-Hada S; Kimata K
    J Biol Chem; 2008 Apr; 283(16):10366-76. PubMed ID: 18281280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
    Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
    Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.
    Zhang F; Zhang Z; Lin X; Beenken A; Eliseenkova AV; Mohammadi M; Linhardt RJ
    Biochemistry; 2009 Sep; 48(35):8379-86. PubMed ID: 19591432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.
    Kreuger J; Salmivirta M; Sturiale L; Giménez-Gallego G; Lindahl U
    J Biol Chem; 2001 Aug; 276(33):30744-52. PubMed ID: 11406624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding.
    Jemth P; Kreuger J; Kusche-Gullberg M; Sturiale L; Giménez-Gallego G; Lindahl U
    J Biol Chem; 2002 Aug; 277(34):30567-73. PubMed ID: 12058038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
    Loo BM; Salmivirta M
    J Biol Chem; 2002 Sep; 277(36):32616-23. PubMed ID: 12077148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
    Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
    Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
    Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides.
    Razi N; Lindahl U
    J Biol Chem; 1995 May; 270(19):11267-75. PubMed ID: 7744762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1.
    Copeland R; Balasubramaniam A; Tiwari V; Zhang F; Bridges A; Linhardt RJ; Shukla D; Liu J
    Biochemistry; 2008 May; 47(21):5774-83. PubMed ID: 18457417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfated derivatives of Escherichia coli K5 polysaccharides as modulators of fibroblast growth factor signaling.
    Borgenström M; Jalkanen M; Salmivirta M
    J Biol Chem; 2003 Dec; 278(50):49882-9. PubMed ID: 14514688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
    Maccarana M; Casu B; Lindahl U
    J Biol Chem; 1993 Nov; 268(32):23898-905. PubMed ID: 8226930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
    Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
    J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs.
    Ye S; Luo Y; Lu W; Jones RB; Linhardt RJ; Capila I; Toida T; Kan M; Pelletier H; McKeehan WL
    Biochemistry; 2001 Dec; 40(48):14429-39. PubMed ID: 11724555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb.
    Luo Y; Ye S; Kan M; McKeehan WL
    J Cell Biochem; 2006 Apr; 97(6):1241-58. PubMed ID: 16315317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
    Guglier S; Hricovíni M; Raman R; Polito L; Torri G; Casu B; Sasisekharan R; Guerrini M
    Biochemistry; 2008 Dec; 47(52):13862-9. PubMed ID: 19117094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
    Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
    J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A binding site for highly sulfated heparan sulfate is identified in the N terminus of the circumsporozoite protein: significance for malarial sporozoite attachment to hepatocytes.
    Ancsin JB; Kisilevsky R
    J Biol Chem; 2004 May; 279(21):21824-32. PubMed ID: 15007056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.